FR6016M - - Google Patents

Info

Publication number
FR6016M
FR6016M FR76931A FR76931A FR6016M FR 6016 M FR6016 M FR 6016M FR 76931 A FR76931 A FR 76931A FR 76931 A FR76931 A FR 76931A FR 6016 M FR6016 M FR 6016M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR76931A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR76931A priority Critical patent/FR6016M/fr
Priority to GB4281467A priority patent/GB1200657A/en
Application granted granted Critical
Publication of FR6016M publication Critical patent/FR6016M/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
FR76931A 1966-09-20 1966-09-20 Expired FR6016M (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR76931A FR6016M (fr) 1966-09-20 1966-09-20
GB4281467A GB1200657A (en) 1966-09-20 1967-09-20 Pharmaceutical anabolic compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR76931A FR6016M (fr) 1966-09-20 1966-09-20

Publications (1)

Publication Number Publication Date
FR6016M true FR6016M (fr) 1968-05-06

Family

ID=8617450

Family Applications (1)

Application Number Title Priority Date Filing Date
FR76931A Expired FR6016M (fr) 1966-09-20 1966-09-20

Country Status (2)

Country Link
FR (1) FR6016M (fr)
GB (1) GB1200657A (fr)

Also Published As

Publication number Publication date
GB1200657A (en) 1970-07-29

Similar Documents

Publication Publication Date Title
AT281852B (fr)
AU5917865A (fr)
AU428063B2 (fr)
AU424443B2 (fr)
AU421822B2 (fr)
AU417216B2 (fr)
AU415165B1 (fr)
AU414526B2 (fr)
AU433222B2 (fr)
FR6016M (fr)
AU612166A (fr)
AU218666A (fr)
AU5895065A (fr)
AU1144366A (fr)
AU1111066A (fr)
AU6703465A (fr)
AU411645B2 (fr)
BE618801A (fr)
AU415780B2 (fr)
AU414093B2 (fr)
AU407778B2 (fr)
AU2390066A (fr)
AU1027866A (fr)
AU6852465A (fr)
AU855865A (fr)